Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Organocatalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN102153501B reveals a metal-free organocatalytic route for chiral pyrrolidines and piperidines, offering significant cost reduction in API manufacturing and supply chain reliability.
Patent CN108484509B reveals a novel organocatalytic route for high-purity spiro compounds. Discover cost-effective manufacturing and scalable supply chain solutions.
Novel route for Dapoxetine HCl using chiral organocatalyst. High yield, >99% ee. Ideal for API intermediates and cost reduction in pharmaceutical manufacturing.
Novel metal-free synthesis of functionalized allenones using N-heterocyclic carbene catalysts. Offers high atom economy and scalability for pharmaceutical intermediates.
Patent CN106242935A reveals a green water-oil two-phase synthesis for triaryl chiral compounds. Achieve high purity and cost reduction in pharmaceutical intermediate manufacturing.
Patent CN103450073A details a novel rigid chiral catalyst synthesis offering superior stereoselectivity and cost-effective manufacturing for complex pharmaceutical intermediates.
Patent CN102153501A details a metal-free organocatalytic synthesis of chiral pyrrolidines and piperidines with high enantioselectivity, offering cost-effective routes for pharmaceutical intermediates.
Novel organocatalysts for asymmetric aldol reactions offering high ee/dr and recyclability for pharmaceutical intermediate manufacturing.
Patent CN115433108A details a metal-free synthesis of chiral hydrazones. This method offers high enantioselectivity and mild conditions for reliable pharmaceutical intermediate manufacturing.
Patent CN102516145A reveals a novel Brønsted acid-catalyzed method for asymmetric selenofunctionalization, offering a metal-free route for high-purity pharmaceutical intermediates with simplified supply chains.
Patent CN114920702A discloses a metal-free asymmetric conjugate addition method for synthesizing optically active imidazolone compounds with high enantioselectivity and yield.
Patent CN109748883B details a metal-free asymmetric ring-opening method for high-purity chiral beta-amino derivatives, offering significant cost reduction and scalability for pharmaceutical intermediates manufacturing.
Patent CN100548979C details a metal-free, high-yield route to optically active 3-aminoindoles using chiral phosphoric acids, offering significant supply chain advantages.
Patent CN115260192B reveals a metal-free NHC catalytic route for nitrogen-containing fused rings, offering cost reduction and high purity for pharmaceutical intermediate manufacturing.
Patent CN108727323B details a green NHC-catalyzed route for trifluoromethyl homoisoflavones, offering cost reduction in pharmaceutical intermediate manufacturing.
Patent CN102766092A reveals a mild, high-enantioselective route to tetrahydroquinoline derivatives using chiral spiro phosphoric acid, offering significant cost reduction in API manufacturing.
Patent CN116041393B reveals a novel N-N axis chiral ligand offering superior stereoselectivity and cost-effective synthesis for asymmetric catalysis applications.
Novel synthesis method for 3,4-dihydropyrano[3,2-b]indol-2-one offers high yield and mild conditions. Reliable supply chain partner for pharmaceutical intermediates manufacturing.
Patent CN114524701B reveals a novel organocatalytic route for N-N axis chiral pyrroles with high enantioselectivity and potent anticancer activity.
Patent CN112209947A reveals a mild organocatalytic route for chiral indoxazinones, offering high enantioselectivity and scalable manufacturing for anticancer drug development.